Real‐world healthcare data, including administrative and electronic medical record
databases, provide a rich source of data for the conduct of pharmacoepidemiologic studies …

Congress mandated the creation of a postmarket Active Risk Identification and Analysis
(ARIA) system containing data on 100 million individuals for monitoring risks associated with …

METHODS: We conducted a retrospective cohort study using longitudinal claims data from a
large US insurer (Anthem, Inc.). We identified patients with CD initiating vedolizumab or …

Objective We investigated the comparative risk of infection with belimumab versus oral
immunosuppressants for the treatment of systemic lupus erythematosus (SLE). Methods …

Compared with notifiable disease surveillance, claims-based algorithms estimate higher
Lyme disease incidence, but their accuracy is unknown. We applied a previously developed …

Background Hand infections are heterogeneous, and some may undergo successful
outpatient management. There are no strict guidelines for determining which patients will …

Objective To assess the association between a comprehensive list of morbidities and
serious infection (SI) in patients with rheumatoid arthritis (RA). Methods This study evaluated …

Background Mycoplasma pneumoniae infection is common in the general population and
may be followed by immune dysfunction, but links with subsequent autoimmune disease …

In epidemiological database studies, the occurrence of an event is measured with error
through an indicator whose specificity is often maximised, at the expense of sensitivity …

Introduction Care of young adults with SLE (YA-SLE, 18–24 years) is challenging due to
major life transitions co-occurring with chronic healthcare needs. Studies have …